GlassScriptPhysician profile
Troy David Lowell
NPI 1295733707
$14,559.09
in general payments reported to CMS, 2019-2025
32 companies · $23.89 in 2025
The $23.89 reported for 2025 was less than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
See the full distribution for Orthopaedic Surgery of the Spine
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,476 · 2020: $1,603 · 2021: $3,757 · 2022: $1,749 · 2023: $2,315 · 2024: $634 · 2025: $23.89.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,631 · Travel and Lodging: $226 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $116.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,631.06 |
| Travel and Lodging | $225.87 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $116.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $4,543.37 | 2019-2024 | Senza |
| Medtronic USA, INC. | $2,569.44 | 2019-2020 | |
| Medtronic, INC. | $2,149.23 | 2021-2023 | Unid_pass, Space-D System 5.5/6.0 Voyager Instrument Set |
| Stryker Corporation | $1,288.78 | 2019-2022 | |
| Relievant Medsystems, INC. | $954.23 | 2022-2023 | Intracept |
| Si-Bone, INC. | $794.34 | 2019-2024 | |
| Cgg Medical INC | $411.53 | 2022-2024 | |
| Smith+Nephew, INC. | $262.49 | 2019-2021 | |
| Boston Scientific Corporation | $260.23 | 2021-2024 | Intracept |
| Integra Lifesciences Corporation | $209.13 | 2022 | |
| Intrinsic Therapeutics | $204.64 | 2023 | Barricaid Acd (Annular Closure Device) |
| Orthofix Medical, INC. | $150.35 | 2021-2022 | |
| Biocomposites INC | $146.53 | 2024 | |
| Endo Pharmaceuticals INC. | $131.35 | 2021 | |
| Trackx Technology, INC. | $99.78 | 2023 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spineology INC. | $50.01 | 2020 | |
| Painteq LLC | $43.08 | 2021 | |
| Zimmer Biomet Holdings, INC. | $30.67 | 2020-2021 | |
| Amgen INC. | $29.71 | 2022-2023 | Prolia, Evenity |
| Musculoskeletal Transplant Foundation INC. | $27.98 | 2023 | |
| Globus Medical, INC. | $23.89 | 2025 | Senza |
| Depuy Synthes Sales INC. | $22.33 | 2023 | Orthovisc, Monovisc |
| Heron Therapeutics, INC. | $20.05 | 2021 | |
| Heraeus Medical, LLC. | $16.91 | 2023 | Palacos |
| Neo Spine USA, INC. | $16.30 | 2020 | |
| Convatec INC. | $16.24 | 2022 | |
| Surgalign Spine Technologies, INC. | $15.65 | 2019 | |
| Ethicon US, LLC | $15.27 | 2022 | |
| Bioventus LLC | $14.78 | 2020 | |
| Acelrx Pharmaceuticals, INC. | $14.73 | 2020 | |
| Misonix INC | $14.67 | 2019 | |
| Kci USA, INC. | $11.40 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Troy Lowell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.